Fifth Third Bancorp
ANGO icon

Fifth Third Bancorp’s AngioDynamics ANGO Stock Holding History

Fifth Third Bancorp’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84K Buy
372
+22
+6% +$250 ﹤0.01% 3941
2026
Q1 		$3.98K Buy
350
+319
+1,029% +$3.46K ﹤0.01% 3914
2025
Q4 		$398 Hold
31
– – ﹤0.01% 2560
2025
Q3 		$346 Sell
31
-18
-37% -$174 ﹤0.01% 2605
2025
Q2 		$486 Buy
+49
New +$480 ﹤0.01% 2490
2023
Q3 		– Sell
-320
Closed -$3.34K – 2582
2023
Q2 		$3.34K Buy
+320
New +$3.08K ﹤0.01% 2314
2023
Q1 		– Sell
-82
Closed -$1.13K – 2757
2022
Q4 		$1.13K Buy
82
+42
+105% +$584 ﹤0.01% 2518
2022
Q3 		$1K Hold
40
– – ﹤0.01% 2506
2022
Q2 		$1K Buy
+40
New +$819 ﹤0.01% 2491
2021
Q4 		– Sell
-67
Closed -$2K – 2668
2021
Q3 		$2K Buy
+67
New +$1.79K ﹤0.01% 2416
2020
Q1 		– Sell
-33
Closed -$1K – 2113
2019
Q4 		$1K Buy
+33
New +$504 ﹤0.01% 2106
2016
Q1 		– Sell
-74
Closed -$1K – 2318
2015
Q4 		$1K Buy
74
+1
+1% +$12 ﹤0.01% 2567
2015
Q3 		$1K Buy
73
+26
+55% +$393 ﹤0.01% 2715
2015
Q2 		$1K Buy
47
+1
+2% +$17 ﹤0.01% 2677
2015
Q1 		$1K Buy
+46
New +$855 ﹤0.01% 2583

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's ANGO Position: Q2 2026 in Review

Fifth Third Bancorp increased its AngioDynamics (ANGO) stake by 6.3% in Q2 2026, buying an estimated $250 and bringing the position to 372 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #3941.

Fifth Third Bancorp first reported a position in ANGO in Q1 2015 and has held it in 15 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Fifth Third Bancorp held 372 shares of AngioDynamics worth $4.84K as of Q2 2026.
  • Fifth Third Bancorp bought 22 AngioDynamics shares in Q2 2026, an estimated $250.
  • AngioDynamics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3941 holding.
  • Fifth Third Bancorp first reported a position in AngioDynamics in Q1 2015 and has held it in 15 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.